128 related articles for article (PubMed ID: 21144873)
1. A novel luciferase and GFP dual reporter virus for rapid and convenient evaluation of hepatitis C virus replication.
Wu Y; Liao Q; Yang R; Chen X; Chen X
Virus Res; 2011 Feb; 155(2):406-14. PubMed ID: 21144873
[TBL] [Abstract][Full Text] [Related]
2. Development of a simple system for screening anti-hepatitis C virus drugs utilizing mutants capable of vigorous replication.
Yu L; Aoki C; Shimizu Y; Shimizu K; Hou W; Yagyu F; Wen X; Oshima M; Iwamoto A; Gao B; Liu W; Gao GF; Kitamura Y
J Virol Methods; 2010 Nov; 169(2):380-4. PubMed ID: 20713089
[TBL] [Abstract][Full Text] [Related]
3. Development of a robust luciferase reporter 1b/2a hepatitis C virus (HCV) for characterization of early stage HCV life cycle inhibitors.
Chan K; Robinson M; Yang H; Cornew S; Delaney Iv WE
Antiviral Res; 2013 Apr; 98(1):85-92. PubMed ID: 23376631
[TBL] [Abstract][Full Text] [Related]
4. A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.
Liu S; Xiao L; Nelson C; Hagedorn CH
PLoS One; 2012; 7(9):e44965. PubMed ID: 23028707
[TBL] [Abstract][Full Text] [Related]
5. Monitoring the antiviral effect of alpha interferon on individual cells.
Kim CS; Jung JH; Wakita T; Yoon SK; Jang SK
J Virol; 2007 Aug; 81(16):8814-20. PubMed ID: 17537862
[TBL] [Abstract][Full Text] [Related]
6. A recombinant replication-competent hepatitis C virus expressing Azami-Green, a bright green-emitting fluorescent protein, suitable for visualization of infected cells.
Hou W; Aoki C; Yu L; Wen X; Xue Y; Gao B; Liu W; Gao GF; Iwamoto A; Kitamura Y
Biochem Biophys Res Commun; 2008 Dec; 377(1):7-11. PubMed ID: 18786508
[TBL] [Abstract][Full Text] [Related]
7. Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex.
Berke JM; Fenistein D; Pauwels F; Bobbaers R; Lenz O; Lin TI; Krausz E; Fanning G
J Virol Methods; 2010 May; 165(2):268-76. PubMed ID: 20153373
[TBL] [Abstract][Full Text] [Related]
8. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus complete life cycle screen for identification of small molecules with pro- or antiviral activity.
Gentzsch J; Hinkelmann B; Kaderali L; Irschik H; Jansen R; Sasse F; Frank R; Pietschmann T
Antiviral Res; 2011 Feb; 89(2):136-48. PubMed ID: 21167208
[TBL] [Abstract][Full Text] [Related]
10. A cell-based bicistronic lentiviral reporter system for identification of inhibitors of the hepatitis C virus internal ribosome entry site.
Lourenço S; Boni S; Furling D; Cosset FL; Cahour A
J Virol Methods; 2009 Jun; 158(1-2):152-9. PubMed ID: 19428584
[TBL] [Abstract][Full Text] [Related]
11. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
Zou G; Xu HY; Qing M; Wang QY; Shi PY
Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
[TBL] [Abstract][Full Text] [Related]
12. High-throughput screening of HCV RNA replication inhibitors by means of a reporter replicon system.
Hao W; Duggal R
Methods Mol Biol; 2009; 510():243-50. PubMed ID: 19009266
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
Kim M; Shin D; Kim SI; Park M
Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
[TBL] [Abstract][Full Text] [Related]
16. Screening for hepatitis C virus antiviral activity with a cell-based secreted alkaline phosphatase reporter replicon system.
Bourne N; Pyles RB; Yi M; Veselenak RL; Davis MM; Lemon SM
Antiviral Res; 2005 Aug; 67(2):76-82. PubMed ID: 15927278
[TBL] [Abstract][Full Text] [Related]
17. A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.
Dansako H; Ikeda M; Abe K; Mori K; Takemoto K; Ariumi Y; Kato N
Virus Res; 2008 Oct; 137(1):72-9. PubMed ID: 18602954
[TBL] [Abstract][Full Text] [Related]
18. Renilla luciferase- Aequorea GFP (Ruc-GFP) fusion protein, a novel dual reporter for real-time imaging of gene expression in cell cultures and in live animals.
Wang Y; Yu YA; Shabahang S; Wang G; Szalay AA
Mol Genet Genomics; 2002 Oct; 268(2):160-8. PubMed ID: 12395190
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a subgenomic replicon for bovine viral diarrhea virus in Huh-7 cells and modulation of interferon-regulated factor 3-mediated antiviral response.
Horscroft N; Bellows D; Ansari I; Lai VC; Dempsey S; Liang D; Donis R; Zhong W; Hong Z
J Virol; 2005 Mar; 79(5):2788-96. PubMed ID: 15708997
[TBL] [Abstract][Full Text] [Related]
20. Screening of hepatitis C virus inhibitors using genotype 1a HCV replicon cell lines.
Robinson M; Tian Y; Pagratis N; Delaney WE
Curr Protoc Microbiol; 2011 Aug; Chapter 17():Unit17.7. PubMed ID: 21805689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
